Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Long-term Safety and Tolerability of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): An Open-Label Extension Study

NCT00554385 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00554385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00554385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Long-term Safety and Tolerability of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): An Open-Label Extension Study
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2007
Completion date
Not reported
Enrollment
283 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/hyperactivity disorder